Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

19.71 USD -0.06 (-0.30%)
Streaming Delayed Price Updated: 1:50 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 522,823
Open 19.95
Bid (Size) 19.69 (3)
Ask (Size) 19.72 (4)
Prev. Close 19.77
Today's Range 19.57 - 19.95
52wk Range 13.03 - 23.92
Shares Outstanding 159,237,889
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
This Alcohol Awareness Month, Reevaluate Your Relationship With Alcohol
Tags Wellness Health & Healthcare COVID/19
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Shares Immuno Oncology Clinical Trial Research
Tags Immuno/Oncology Healthcare Industry News Healthcare Innovation
From 3BL Media: Corporate Social Responsibility, Energy and Health News

Performance

YTD
-0.15%
-0.15%
1 Month
-0.20%
-0.20%
3 Month
-10.41%
-10.41%
6 Month
+14.26%
+14.26%
1 Year
+27.74%
+27.74%

More News

Read More
Alkermes Celebrates National Minority Health Month
Tags Reduced Inequalities Mental Health NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Provides Resources for Talking to a Loved One About Alcohol Dependence
Tags Life Science Awareness Day NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
How Posting About Alcohol May Be Hurting Those Having Trouble Coping With the Pandemic
Tags pandemic Chronic Illness alcohol use disorder
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Celebrates World Health Day 2021
Tags NASDAQ:ALKS Good Health and Well/Being Events, Media & Communications
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in Combination With KEYTRUDA® in Patients With Platinum-Resistant Ovarian Cancer
From PR Newswire
Alkermes Employee Reflects on His Family's Experience with Cancer and How It Impacts His Work
Tags Alkermes Life Science Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Celebrates National Cancer Control Month
Tags Alkermes Life Science Healthcare Industry News
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes + Mental Health Missions
Tags NASDAQ:ALKS Good Health and Well/Being Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Kicks Off Alcohol Awareness Month
Tags Good Health and Well/Being NASDAQ:ALKS Wellness
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.